REYON Pharmaceutical Co., Ltd. announced that it expects to receive KRW 40 billion in funding from Mirae Asset Daewoo Co., Ltd., KDB Capital Corp., Eum Private Equity, Industrial Bank of Korea, Investment Arm
July 20, 2017
Share
REYON Pharmaceutical Co., Ltd. (KOSE:A102460) announced a private placement of 1st series unregistered coupon unguaranteed private convertible bonds for gross proceeds of KRW 40,000,000,000 on July 20, 2017. The transaction will include participation from IBK Link Hidden Champion Growth No. 1 PEF for gross proceeds of KRW 20,000,000,000, Mirae Asset Daewoo Co., Ltd. (KOSE:A006800) for gross proceeds of KRW 10,000,000,000, and KDB Capital Corp.
for gross proceeds of KRW 10,000,000,000. The bonds are issued at par and do not carry any coupon. The bonds would mature on July 21, 2022.
The bonds are fully convertible into 1,878,287 shares of the company at a fixed conversion price of KRW 21,296 between a period of July 21, 2018 to June 21, 2022. The subscription date and payment date is July 21, 2017. The transaction has been approved by the board of directors of the company.
REYON PHARMACEUTICAL Co. Ltd. is a Korea-based company engaged in the provision of pharmaceutical products. The Companyâs products consist of remedies for circulatory systems, endocrine systems, digestive systems, respiratory systems, urinary systems and nervous systems, as well as eye drops, antibiotics, fever reducers, painkillers, anti-inflammatory drugs, antihistaminic agents, enzyme preparations, arthritis remedies, antitumor drugs and topical anesthetics, among others. It also produces pharmaceutical raw materials, such as arbekacin sulfate, alibendol, carvedilol, enocitabine, gemcitabine, glimepiride, lamotrigine, meloxicam, oxaliplatin, pioglitazone hydrochloride, ramipril, streptokinase, tacrolimus, thioctic acid, teicoplanin, voglibose and others.
REYON Pharmaceutical Co., Ltd. announced that it expects to receive KRW 40 billion in funding from Mirae Asset Daewoo Co., Ltd., KDB Capital Corp., Eum Private Equity, Industrial Bank of Korea, Investment Arm